Atai Life Sciences Basic EPS 2020-2025 | ATAI

Atai Life Sciences basic eps from 2020 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Atai Life Sciences Annual Basic EPS
2024 $-0.93
2023 $-0.25
2022 $-0.98
2021 $-1.21
2020 $-1.83
2019 $-0.16
Atai Life Sciences Quarterly Basic EPS
2025-03-31 $-0.15
2024-12-31 $-0.24
2024-09-30 $-0.16
2024-06-30 $-0.36
2024-03-31 $-0.17
2023-12-31 $-0.11
2023-09-30 $0.28
2023-06-30 $-0.21
2023-03-31 $-0.21
2022-12-31 $-0.28
2022-09-30 $-0.22
2022-06-30 $-0.24
2022-03-31 $-0.24
2021-12-31 $-0.64
2021-09-30 $-0.21
2021-06-30 $-0.37
2021-03-31 $0.01
2020-12-31 $-0.91
2020-09-30 $-0.92
2020-06-30 $-0.18
2020-03-31 $0.18
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.525B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.765B 18.49
Encompass Health (EHC) United States $11.937B 25.31
DaVita (DVA) United States $10.763B 15.13
Elanco Animal Health (ELAN) United States $7.400B 15.85
Chemed (CHE) United States $6.728B 21.15
Option Care Health (OPCH) United States $4.893B 21.81
RadNet (RDNT) United States $4.163B 264.19
Amedisys (AMED) United States $3.189B 21.45
Addus HomeCare (ADUS) United States $2.041B 22.41
LifeStance Health (LFST) United States $1.754B 0.00
Astrana Health (ASTH) United States $1.396B 34.58
U.S Physical Therapy (USPH) United States $1.132B 29.22
Pennant (PNTG) United States $0.870B 31.94
Aveanna Healthcare Holdings (AVAH) United States $0.792B 45.11
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00